Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Graft-versus-host disease | R-HSA-1643685 | map05332 | doxorubicin | 4044 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | doxorubicin | 4044 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | doxorubicin | 4044 | drug-path |
PPAR signaling pathway | R-HSA-168638 | map03320 | doxorubicin | 4044 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | doxorubicin | 4044 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | doxorubicin | 4044 | drug-path |
Taste transduction | R-HSA-162582 | map04742 | doxorubicin | 4044 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | doxorubicin | 4044 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | doxorubicin | 4044 | drug-path |
Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | doxorubicin | 4044 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | doxorubicin | 4044 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | doxorubicin | 4044 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | doxorubicin | 4044 | drug-path |
Primary immunodeficiency | R-HSA-5601905 | map05340 | doxorubicin | 4044 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | doxorubicin | 4044 | drug-path |
Long-term potentiation | R-HSA-9620244 | map04720 | doxorubicin | 4044 | drug-path |
Vibrio cholerae infection | R-HSA-9609646 | map05110 | doxorubicin | 4044 | drug-path |
Asthma | R-HSA-444620 | map05310 | doxorubicin | 4044 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | doxorubicin | 4044 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | doxorubicin | 4044 | drug-path |